Author

Henning Sand Christensen

OpenAlex ID: A5043698361

Minimal Residual Disease (MRD) follow up of MM patients obtaining stringent complete remission (sCR) in the NMSG/EMN02 clinical trial – defining sCR numbers and prediction of disease progression by multiparametric flow cytometry (MFC).

2018 · Hans Erik Johnsen, Alexander Schmitz, et al. · VBN Forskningsportal (Aalborg Universitet)

Works count: 1

Citation count:

H-index:

I10-index: